Search This Blog

Thursday, February 27, 2020

NovoCure EPS beats by $0.02, beats on revenue

NovoCure (NASDAQ:NVCR): Q4 GAAP EPS of $0.04 beats by $0.02.
Revenue of $99.23M (+42.4% Y/Y) beats by $0.13M.
Press Release
https://seekingalpha.com/news/3546298-novocure-eps-beats-0_02-beats-on-revenue
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)